CUL1 and Miyoshi myopathy: A bubble heatmap depicted the connection between common agents treating MM and gene expression in Figure 4D. UBE2D1 conferred bortezomib resistance while CUL1, PSMC2, and UBE2B were sensitive to BTZ.